The Joint Corp. (NASDAQ: JYNT) Stock Competitors & Peer Comparison
See JYNT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for JYNT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| JYNT | $8.23 | -0.60% | 118.6M | 83.20 | $0.10 | N/A |
| HCA | $401.46 | -1.89% | 87.7B | 13.98 | $28.96 | +0.74% |
| THC | $260.11 | -1.28% | 21.3B | 15.37 | $17.24 | N/A |
| FMS | $22.51 | +0.16% | 12.2B | 8.52 | $2.66 | +3.81% |
| EHC | $121.08 | -1.24% | 12.1B | 20.85 | $5.84 | +0.62% |
| DVA | $181.48 | -0.10% | 11.8B | 14.37 | $12.80 | N/A |
| UHS | $171.12 | +1.13% | 10.3B | 7.53 | $22.54 | +0.47% |
| ENSG | $171.56 | -0.31% | 10B | 24.75 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $521.66 | -0.53% | 6.8B | 24.06 | $21.61 | +0.48% |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
JYNT vs HCA Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, HCA has a market cap of 87.7B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while HCA trades at $401.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas HCA's P/E ratio is 13.98. In terms of profitability, JYNT's ROE is +0.22%, compared to HCA's ROE of -1.13%. Regarding short-term risk, JYNT is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
JYNT vs THC Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, THC has a market cap of 21.3B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while THC trades at $260.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas THC's P/E ratio is 15.37. In terms of profitability, JYNT's ROE is +0.22%, compared to THC's ROE of +0.51%. Regarding short-term risk, JYNT is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
JYNT vs FMS Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while FMS trades at $22.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas FMS's P/E ratio is 8.52. In terms of profitability, JYNT's ROE is +0.22%, compared to FMS's ROE of +0.07%. Regarding short-term risk, JYNT is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
JYNT vs EHC Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while EHC trades at $121.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas EHC's P/E ratio is 20.85. In terms of profitability, JYNT's ROE is +0.22%, compared to EHC's ROE of +0.25%. Regarding short-term risk, JYNT is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
JYNT vs DVA Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, DVA has a market cap of 11.8B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while DVA trades at $181.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas DVA's P/E ratio is 14.37. In terms of profitability, JYNT's ROE is +0.22%, compared to DVA's ROE of -1.24%. Regarding short-term risk, JYNT is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
JYNT vs UHS Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while UHS trades at $171.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas UHS's P/E ratio is 7.53. In terms of profitability, JYNT's ROE is +0.22%, compared to UHS's ROE of +0.21%. Regarding short-term risk, JYNT is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
JYNT vs ENSG Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while ENSG trades at $171.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas ENSG's P/E ratio is 24.75. In terms of profitability, JYNT's ROE is +0.22%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, JYNT is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
JYNT vs OSH Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas OSH's P/E ratio is -17.65. In terms of profitability, JYNT's ROE is +0.22%, compared to OSH's ROE of +4.64%. Regarding short-term risk, JYNT is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
JYNT vs CHE Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while CHE trades at $521.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas CHE's P/E ratio is 24.06. In terms of profitability, JYNT's ROE is +0.22%, compared to CHE's ROE of +0.29%. Regarding short-term risk, JYNT is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
JYNT vs PACS Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, PACS has a market cap of 6.7B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while PACS trades at $43.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas PACS's P/E ratio is 22.49. In terms of profitability, JYNT's ROE is +0.22%, compared to PACS's ROE of +0.27%. Regarding short-term risk, JYNT is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check PACS's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
JYNT vs HIMS Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while HIMS trades at $27.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas HIMS's P/E ratio is -43.30. In terms of profitability, JYNT's ROE is +0.22%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, JYNT is more volatile compared to HIMS. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
JYNT vs LHCG Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas LHCG's P/E ratio is 82.83. In terms of profitability, JYNT's ROE is +0.22%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, JYNT is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
JYNT vs LFST Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while LFST trades at $12.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas LFST's P/E ratio is 95.88. In terms of profitability, JYNT's ROE is +0.22%, compared to LFST's ROE of +0.03%. Regarding short-term risk, JYNT is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
JYNT vs CON Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while CON trades at $34.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas CON's P/E ratio is 21.68. In terms of profitability, JYNT's ROE is +0.22%, compared to CON's ROE of +0.47%. Regarding short-term risk, JYNT is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
JYNT vs OPCH Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while OPCH trades at $23.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas OPCH's P/E ratio is 14.08. In terms of profitability, JYNT's ROE is +0.22%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, JYNT is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
JYNT vs NHC Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, NHC has a market cap of 3.4B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while NHC trades at $221.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas NHC's P/E ratio is 27.82. In terms of profitability, JYNT's ROE is +0.22%, compared to NHC's ROE of +0.13%. Regarding short-term risk, JYNT is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
JYNT vs AMED Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AMED's P/E ratio is 39.30. In terms of profitability, JYNT's ROE is +0.22%, compared to AMED's ROE of +0.11%. Regarding short-term risk, JYNT is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
JYNT vs AVAH Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AVAH has a market cap of 3B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AVAH trades at $13.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AVAH's P/E ratio is 19.97. In terms of profitability, JYNT's ROE is +0.22%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, JYNT is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
JYNT vs BKD Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, BKD has a market cap of 2.8B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while BKD trades at $12.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas BKD's P/E ratio is -20.29. In terms of profitability, JYNT's ROE is +0.22%, compared to BKD's ROE of +4.06%. Regarding short-term risk, JYNT is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
JYNT vs ACHC Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while ACHC trades at $27.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas ACHC's P/E ratio is 14.14. In terms of profitability, JYNT's ROE is +0.22%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, JYNT is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check ACHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
JYNT vs GRDN Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while GRDN trades at $41.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas GRDN's P/E ratio is 35.76. In terms of profitability, JYNT's ROE is +0.22%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, JYNT is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
JYNT vs MD Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while MD trades at $26.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas MD's P/E ratio is 12.07. In terms of profitability, JYNT's ROE is +0.22%, compared to MD's ROE of +0.20%. Regarding short-term risk, JYNT is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
JYNT vs ADUS Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while ADUS trades at $119.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas ADUS's P/E ratio is 17.78. In terms of profitability, JYNT's ROE is +0.22%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, JYNT is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
JYNT vs SEM Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas SEM's P/E ratio is 15.43. In terms of profitability, JYNT's ROE is +0.22%, compared to SEM's ROE of +0.08%. Regarding short-term risk, JYNT is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
JYNT vs ASTH Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while ASTH trades at $37.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas ASTH's P/E ratio is 46.35. In terms of profitability, JYNT's ROE is +0.22%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, JYNT is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
JYNT vs SGRY Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while SGRY trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas SGRY's P/E ratio is 36.56. In terms of profitability, JYNT's ROE is +0.22%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, JYNT is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
JYNT vs AMEH Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AMEH's P/E ratio is 39.25. In terms of profitability, JYNT's ROE is +0.22%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, JYNT is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check AMEH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
JYNT vs SNDA Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while SNDA trades at $39.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas SNDA's P/E ratio is -6.09. In terms of profitability, JYNT's ROE is +0.22%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, JYNT is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check SNDA's competition here
Ardent Health Inc. (NYSE: ARDT)
JYNT vs ARDT Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while ARDT trades at $10.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas ARDT's P/E ratio is 8.80. In terms of profitability, JYNT's ROE is +0.22%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, JYNT is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
JYNT vs HCSG Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while HCSG trades at $21.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas HCSG's P/E ratio is 17.46. In terms of profitability, JYNT's ROE is +0.22%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, JYNT is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
JYNT vs AGL Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AGL trades at $90.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AGL's P/E ratio is -5.74. In terms of profitability, JYNT's ROE is +0.22%, compared to AGL's ROE of -1.19%. Regarding short-term risk, JYNT is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
JYNT vs INNV Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while INNV trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas INNV's P/E ratio is -119.44. In terms of profitability, JYNT's ROE is +0.22%, compared to INNV's ROE of -0.09%. Regarding short-term risk, JYNT is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check INNV's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
JYNT vs NUTX Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while NUTX trades at $191.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas NUTX's P/E ratio is 7.65. In terms of profitability, JYNT's ROE is +0.22%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, JYNT is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check NUTX's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
JYNT vs PNTG Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while PNTG trades at $39.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas PNTG's P/E ratio is 28.79. In terms of profitability, JYNT's ROE is +0.22%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, JYNT is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
JYNT vs AMN Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AMN trades at $33.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AMN's P/E ratio is 11.23. In terms of profitability, JYNT's ROE is +0.22%, compared to AMN's ROE of +0.15%. Regarding short-term risk, JYNT is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
JYNT vs BKDT Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas BKDT's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, JYNT is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
JYNT vs USPH Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while USPH trades at $79.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas USPH's P/E ratio is 31.24. In terms of profitability, JYNT's ROE is +0.22%, compared to USPH's ROE of -0.01%. Regarding short-term risk, JYNT is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
JYNT vs TALK Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas TALK's P/E ratio is 774.34. In terms of profitability, JYNT's ROE is +0.22%, compared to TALK's ROE of +0.00%. Regarding short-term risk, JYNT is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
JYNT vs GMRS Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, GMRS has a market cap of 727M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while GMRS trades at $13.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas GMRS's P/E ratio is 5.98. In terms of profitability, JYNT's ROE is +0.22%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, JYNT is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
JYNT vs EHAB Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas EHAB's P/E ratio is -197.14. In terms of profitability, JYNT's ROE is +0.22%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, JYNT is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
JYNT vs STLN Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, STLN has a market cap of 592.9M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while STLN trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas STLN's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to STLN's ROE of +2.10%. Regarding short-term risk, JYNT is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
JYNT vs TOI Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas TOI's P/E ratio is -14.25. In terms of profitability, JYNT's ROE is +0.22%, compared to TOI's ROE of +2.10%. Regarding short-term risk, JYNT is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
JYNT vs SRTA Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, SRTA has a market cap of 460.3M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while SRTA trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas SRTA's P/E ratio is -25.08. In terms of profitability, JYNT's ROE is +0.22%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, JYNT is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
JYNT vs MCTA Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas MCTA's P/E ratio is 419.36. In terms of profitability, JYNT's ROE is +0.22%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, JYNT is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
JYNT vs CYH Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, CYH has a market cap of 407.5M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while CYH trades at $2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas CYH's P/E ratio is 3.96. In terms of profitability, JYNT's ROE is +0.22%, compared to CYH's ROE of +0.21%. Regarding short-term risk, JYNT is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
JYNT vs AUNA Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AUNA has a market cap of 390.8M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AUNA trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AUNA's P/E ratio is 4.76. In terms of profitability, JYNT's ROE is +0.22%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, JYNT is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
JYNT vs VMD Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, VMD has a market cap of 345.8M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while VMD trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas VMD's P/E ratio is 25.22. In terms of profitability, JYNT's ROE is +0.22%, compared to VMD's ROE of +0.10%. Regarding short-term risk, JYNT is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
JYNT vs CSU Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas CSU's P/E ratio is 0.67. In terms of profitability, JYNT's ROE is +0.22%, compared to CSU's ROE of -0.33%. Regarding short-term risk, JYNT is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
JYNT vs AIRS Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AIRS has a market cap of 197.2M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AIRS trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AIRS's P/E ratio is -93.17. In terms of profitability, JYNT's ROE is +0.22%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, JYNT is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check AIRS's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
JYNT vs FVE Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas FVE's P/E ratio is -5.64. In terms of profitability, JYNT's ROE is +0.22%, compared to FVE's ROE of -0.15%. Regarding short-term risk, JYNT is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
JYNT vs KDLYW Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas KDLYW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, JYNT is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
JYNT vs PARK Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, PARK has a market cap of 92.2M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while PARK trades at $20.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas PARK's P/E ratio is 27.61. In terms of profitability, JYNT's ROE is +0.22%, compared to PARK's ROE of -0.18%. Regarding short-term risk, JYNT is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
JYNT vs BTMD Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, BTMD has a market cap of 68.1M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while BTMD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas BTMD's P/E ratio is 14.05. In terms of profitability, JYNT's ROE is +0.22%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, JYNT is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
JYNT vs ALR Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas ALR's P/E ratio is -1.11. In terms of profitability, JYNT's ROE is +0.22%, compared to ALR's ROE of -0.15%. Regarding short-term risk, JYNT is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
JYNT vs DCGO Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, DCGO has a market cap of 39.8M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while DCGO trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas DCGO's P/E ratio is -0.22. In terms of profitability, JYNT's ROE is +0.22%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, JYNT is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
JYNT vs CCEL Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, CCEL has a market cap of 34.5M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while CCEL trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas CCEL's P/E ratio is -14.27. In terms of profitability, JYNT's ROE is +0.22%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, JYNT is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
JYNT vs IMAC Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas IMAC's P/E ratio is -2.27. In terms of profitability, JYNT's ROE is +0.22%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, JYNT is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
JYNT vs PIII Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, PIII has a market cap of 30.6M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while PIII trades at $8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas PIII's P/E ratio is -0.28. In terms of profitability, JYNT's ROE is +0.22%, compared to PIII's ROE of +1.61%. Regarding short-term risk, JYNT is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
JYNT vs EUDA Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, EUDA has a market cap of 25.2M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while EUDA trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas EUDA's P/E ratio is -25.45. In terms of profitability, JYNT's ROE is +0.22%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, JYNT is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check EUDA's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
JYNT vs PIIIW Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, PIIIW has a market cap of 24.5M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas PIIIW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, JYNT is more volatile compared to PIIIW. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO-WT)
JYNT vs CANO-WT Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, JYNT is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
JYNT vs AIH Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AIH's P/E ratio is -2.78. In terms of profitability, JYNT's ROE is +0.22%, compared to AIH's ROE of +1.16%. Regarding short-term risk, JYNT is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
JYNT vs CANO Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas CANO's P/E ratio is -0.01. In terms of profitability, JYNT's ROE is +0.22%, compared to CANO's ROE of -1.49%. Regarding short-term risk, JYNT is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
JYNT vs FPCG Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas FPCG's P/E ratio is 0.09. In terms of profitability, JYNT's ROE is +0.22%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, JYNT is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
JYNT vs FTRP Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas FTRP's P/E ratio is -1.22. In terms of profitability, JYNT's ROE is +0.22%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, JYNT is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
JYNT vs AMS Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AMS's P/E ratio is -5.66. In terms of profitability, JYNT's ROE is +0.22%, compared to AMS's ROE of -0.07%. Regarding short-term risk, JYNT is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
JYNT vs BMGL Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, BMGL has a market cap of 7.6M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while BMGL trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas BMGL's P/E ratio is -0.91. In terms of profitability, JYNT's ROE is +0.22%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, JYNT is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
JYNT vs AIDX Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AIDX has a market cap of 7.2M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AIDX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AIDX's P/E ratio is -1.12. In terms of profitability, JYNT's ROE is +0.22%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, JYNT is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
JYNT vs MODV Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas MODV's P/E ratio is -0.06. In terms of profitability, JYNT's ROE is +0.22%, compared to MODV's ROE of +1.36%. Regarding short-term risk, JYNT is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
JYNT vs GBNH Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas GBNH's P/E ratio is -0.06. In terms of profitability, JYNT's ROE is +0.22%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, JYNT is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check GBNH's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
JYNT vs STLNW Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, STLNW has a market cap of 5.3M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas STLNW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, JYNT is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check STLNW's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
JYNT vs RHE-PA Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, JYNT's ROE is +0.22%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, JYNT is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
JYNT vs RHE Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas RHE's P/E ratio is -1.79. In terms of profitability, JYNT's ROE is +0.22%, compared to RHE's ROE of -1.31%. Regarding short-term risk, JYNT is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
JYNT vs TOIIW Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, JYNT's ROE is +0.22%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, JYNT is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
JYNT vs IMACW Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas IMACW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, JYNT is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
JYNT vs EDVA Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, EDVA has a market cap of 1.7M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while EDVA trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas EDVA's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to EDVA's ROE of N/A. Regarding short-term risk, JYNT is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
JYNT vs EUDAW Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, JYNT's ROE is +0.22%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, JYNT is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
JYNT vs CCM Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, CCM has a market cap of 681.5K. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while CCM trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas CCM's P/E ratio is -0.31. In terms of profitability, JYNT's ROE is +0.22%, compared to CCM's ROE of +0.06%. Regarding short-term risk, JYNT is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
JYNT vs NIVF Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while NIVF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas NIVF's P/E ratio is 0.56. In terms of profitability, JYNT's ROE is +0.22%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, JYNT is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
JYNT vs NIVFW Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, NIVFW has a market cap of 45.7K. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, JYNT's ROE is +0.22%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, JYNT is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
JYNT vs MNDR Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, MNDR has a market cap of 34.9K. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while MNDR trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas MNDR's P/E ratio is -0.04. In terms of profitability, JYNT's ROE is +0.22%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, JYNT is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
JYNT vs TALKW Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas TALKW's P/E ratio is 0.00. In terms of profitability, JYNT's ROE is +0.22%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, JYNT is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check TALKW's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
JYNT vs SLHG Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas SLHG's P/E ratio is -1.48. In terms of profitability, JYNT's ROE is +0.22%, compared to SLHG's ROE of N/A. Regarding short-term risk, JYNT is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check SLHG's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
JYNT vs SLHGP Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, JYNT's ROE is +0.22%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, JYNT is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check SLHGP's competition here
Almost Family Inc. (NASDAQ: AFAM)
JYNT vs AFAM Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas AFAM's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, JYNT is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
JYNT vs TLMD Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas TLMD's P/E ratio is -1.60. In terms of profitability, JYNT's ROE is +0.22%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, JYNT is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check TLMD's competition here
Hanger, Inc. (NYSE: HNGR)
JYNT vs HNGR Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas HNGR's P/E ratio is 19.71. In terms of profitability, JYNT's ROE is +0.22%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, JYNT is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check HNGR's competition here
New Frontier Health Corporation (NYSE: NFH)
JYNT vs NFH Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, NFH has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas NFH's P/E ratio is -19.75. In terms of profitability, JYNT's ROE is +0.22%, compared to NFH's ROE of -0.06%. Regarding short-term risk, JYNT is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check NFH's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
JYNT vs DVCR Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas DVCR's P/E ratio is 28.34. In terms of profitability, JYNT's ROE is +0.22%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, JYNT is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check DVCR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
JYNT vs ATIP-WT Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, JYNT is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check ATIP-WT's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
JYNT vs TLMDW Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas TLMDW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, JYNT is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check TLMDW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
JYNT vs TVTY Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas TVTY's P/E ratio is 19.06. In terms of profitability, JYNT's ROE is +0.22%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, JYNT is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check TVTY's competition here
DocGo Inc. (NASDAQ: DCGOW)
JYNT vs DCGOW Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas DCGOW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is +0.22%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, JYNT is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for JYNT.Check DCGOW's competition here
Kindred Healthcare, Inc. (NYSE: KND)
JYNT vs KND Comparison September 2026
The Joint Corp. (NASDAQ: JYNT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 118.6M. In comparison, KND has a market cap of 0. Regarding current trading prices, JYNT is priced at $8.23 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of 83.20, whereas KND's P/E ratio is -1.14. In terms of profitability, JYNT's ROE is +0.22%, compared to KND's ROE of -0.53%. Regarding short-term risk, JYNT is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for JYNT.Check KND's competition here